November 2020

Cutaneous Malignancies Forum

Las Vegas, NV

Independent Symposia

Thursday, November 7, 2019

7:15 AM - 8:00 AM

What Sets Taltz Apart
Faculty:  Craig L. Leonardi, MD
Sponsored by: Lilly

9:30 AM - 10:30 AM

Deep Discovery: Focusing In-Depth on Treatment Strategies for Psoriasis, PsA, and AD
Faulty: Joel Gelfand, MD, MSCE and Richard Martin, MD, MA
This activity is provided by Forefront Collaborative and supported by an educational grant from Lilly. Additional 1.0 AMA PRA Category 1 Credit™ available.

12:30 PM - 1:15 PM

Uncovering Clearance
Faculty: Bruce Strober, MD,  PhD, FAAD
Sponsored by: AbbVie 

5:30 PM - 6:15 PM

Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
Faculty: H.L. Greenberg, MD
Sponsored by:  Celgene

 

Friday, November 8, 2019

7:10 AM - 7:55 AM

SILIQ: The First and only IL-17 Receptor Blocker for Psoriasis 
Faculty: Bruce Strober, MD,  PhD, FAAD
Sponsored by: Ortho Dermatologics

12:45 PM - 1:30 PM

Managing Continued Treatment for Chronic Moderate to Severe Plaque Psoriasis
Faculty: Francisco Kerdel, MD 
Sponsored by: Amgen 

6:00 PM – 6:45 PM

Steroid-Free EUCRISA: A Treatment Option for Mild-Moderate Atopic Dermatitis in Patients 2 Years and Older
Faculty: Miriam Bettencourt, MD 
Sponsored by: Pfizer

 

Saturday, November 9, 2019

7:10 AM - 8:10 AM

Understanding Legal Tools; Keys to Lawsuit Prevention, Tax Reduction and License Protection
Faculty: Dan McNeff
Sponsored by: Legally Mine 

9:30 AM - 10:30 AM

A 360-View of Psoriasis: Are You Treating to the Standards?
Faculty:  Andrew Blauvelt, MD, MBA, Kristina Callis Duffin, MD and Jashin J. Wu, MD
This activity is provided by Medscape and supported by an educational grant from Ortho Dermatologics. Additional 1.0 AMA PRA Category 1 Credit™ available.

10:45 AM - 11:45 AM

Diving Beneath the Surface to Improve and Individualize Care in Moderate-to Severe Atopic Dermatitis
Faculty: Linda F. Stein Gold, MD
This activity is jointly provided by Postgraduate Institute for Medicine and Global Academy for Medical Education and supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. Additional 1.0 AMA PRA Category 1 Credit™ available.

 

 

Follow Us

Jointly Provided By

In Association With